#USA #New York #Class Action #Pomerantz Law Firm #Hims & Hers

Investor Alert: Class Action Lawsuit Filed Against Hims & Hers Health, Inc.

Pomerantz Law Firm is making significant waves as it announces a class action lawsuit against Hims & Hers Health, Inc., traded on the New York Stock Exchange under the symbol HIMS. Investors who have faced losses related to their investments in Hims & Hers are being urged to take notice as important deadlines are looming.

Overview of the Claims

The core of the lawsuit revolves around allegations that Hims & Hers, along with some of its corporate officers and directors, have engaged in securities fraud and other unlawful business practices. This follows the Federal Trade Commission (FTC)'s actions indicating deceptive practices related to customer privacy and billing.

FTC's Charges

On July 29, 2026, the FTC announced its lawsuit against Hims & Hers, stating that the company improperly shared sensitive health information of consumers with third-party advertising platforms while marketing its telehealth services as private and secure. The complaints extend to irregularities concerning billing practices, with allegations that customers incur charges for prescriptions immediately upon submitting their information, rather than being informed clearly about the process.

The allegation that sensitive health information was shared with companies such as Meta Platforms, Inc. and Snap Inc. adds a further layer of concern regarding consumer privacy. Following this announcement, Hims & Hers' stock price took a significant hit, dropping 14.73%, closing at $25.00 per share.

Call for Action to Investors

Investors affected by this situation should act quickly. They have until November 2, 2026, to contact Pomerantz Law Firm and request to be appointed as Lead Plaintiff in the class action lawsuit. This is an opportunity for those who purchased or acquired Hims & Hers securities within the class period to join the fight against corporate misconduct. Individuals interested can reach out to Danielle Peyton via email or phone provided in the firm's announcements. Furthermore, the details of the complaint can be accessed at pomerantzlaw.com.

About Pomerantz Law Firm

Pomerantz LLP is recognized as a pioneering law firm specializing in corporate, securities, and antitrust class litigation. Founded by Abraham L. Pomerantz, a notable figure in securities law, the firm stands as a pillar in the fight against corporate fraud and protecting the rights of institutional and individual investors. Over the years, Pomerantz has secured numerous multimillion-dollar settlements for its clients, reflecting its dedication to high standards in legal practice. The firm's global presence boasts offices in New York, Chicago, Los Angeles, London, Paris, and Tel Aviv.

Conclusion

The unfolding situation with Hims & Hers Health, Inc. serves as a poignant reminder to investors of the importance of vigilance in corporate governance and transparency. As the legal landscape continues to evolve, investors are encouraged to stay informed about their rights and opportunities available to them in the face of potential corporate misconduct. For more information, interested parties can visit the aforementioned website or get in touch with Pomerantz LLP directly.